快樂小藥師
目前分類:MedScape (166)
- Dec 25 Sun 2011 09:38
[Medscape][Ask the Experts]Can Iron Worsen Infection? 鐵劑會惡化感染嗎?
- Nov 16 Wed 2011 03:00
[Medscape][Medscape Medical News]Oral Microbial Profiles Differ With Varying Pneumonia Risk
The mix of oral bacteria differs in individuals with different risks for pneumonia, Samit Joshi, DO, MPH, a fellow in infectious diseases at the Yale School of Medicine in New Haven, Connecticut, reported here at the Infectious Diseases Society of America (IDSA) 49th Annual Meeting.
- Nov 09 Wed 2011 11:58
[Medscape][Medscape Education Oncology]What Pharmacists Should Know About Stem Cell Transplantation
藥師應該對幹細胞移植知道什麼呢?
- Oct 19 Wed 2011 07:16
[Medscape][Medical News]Frequent Aspirin Use Tied to Aging Macula Disorder
經常使用阿斯匹靈與老化黃斑病變有關
Frequent use of aspirin is associated with early aging macula disorder (AMD), as well as wet late AMD, and risks for those problems appear to be linked to how often aspirin is consumed.
- Sep 27 Tue 2011 05:59
[Medscape]EMA Recommends Restricting Use of Dronedarone
The European Medicines Agency (EMA) recommends restricting the use of the antiarrhythmic medication dronedarone (Multaq, Sanofi-Aventis) [1]. The committee states that because of the increased risk of liver, lung, and cardiovascular adverse events, dronedarone "should only be prescribed after alternative treatment options have been considered." Patients currently taking dronedarone should have their treatment reassessed by their physician at their next scheduled visit, the EMA reports.
- Sep 26 Mon 2011 05:56
[Medscape][Medscape Medical News][FDA Approvals]Eculizumab Approved for Rare Pediatric Blood Disorder
The US Food and Drug Administration (FDA) today approved eculizumab (Soliris, Alexion Pharmaceuticals) as the first drug to treat atypical hemolytic uremic syndrome (aHUS), a rare and chronic blood disease that disproportionately affects children.
- Sep 25 Sun 2011 05:53
[Medscape][Medscape Medical News]EMA: Restrict Terpenoid-Containing Suppositories in Children
The European Medicines Agency has changed its recommendations for suppositories that contain terpenic derivatives. It now says that they should not be used in children younger than 30 months or in children who have experienced febrile convulsion, epilepsy, or recent anorectal lesions.
- Sep 24 Sat 2011 05:32
[Medscape][Cochrane][MEDLINE Abstract]Probiotics for preventing acute upper respiratory tract infections
Cochrane Database Syst Rev. 2011; 9:CD006895 (ISSN: 1469-493X)
- Sep 23 Fri 2011 05:20
[Medscape][MEDLINE Abstract]Antibiotics, Acne, and Staphylococcus aureus Colonization.
Arch Dermatol. 2011; 147(8):917-21 (ISSN: 1538-3652)
Fanelli M; Kupperman E; Lautenbach E; Edelstein PH; Margolis DJ
Department of Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 815 Blockley Hall, 423 Guardian Dr, Philadelphia, PA 19104. dmargoli@cceb.med.upenn.edu.
- Sep 22 Thu 2011 05:58
[Medscape][FDA Approvals]FDA Approves Once-Daily, Single-Tablet Combo HIV Drug
Clinical Context
On August 10, the US Food and Drug Administration (FDA) approved Complera, a combination of the nonnucleoside reverse transcriptase inhibitor (NNRTI) rilpivirine and the nucleoside reverse transcriptase inhibitors (NRTIs) tenofovir and emtricitabine, for treatment of HIV infection. This combination drug results in the same blood levels as each of the 3 drugs individually, according to the findings of a bioequivalence study. Approval of Complera was based on the ECHO and THRIVE phase 3 randomized trials of rilpivirine, without performance of any new trials.
- Sep 21 Wed 2011 07:15
[Medscape][Ask the Experts]What IV Methylprednisolone Dose Is Optimal for Acute Asthma? 極性氣喘的methylprednisolone注射劑量該如何調整?
Question:
What is the optimal dose of intravenous methylprednisolone for acute asthma exacerbation?
- Sep 11 Sun 2011 05:01
[Medscape][MEDLINE Abstract]Association between use of HMG CoA reductase inhibitors and mortality in HIV-infected patients
INTRODUCTION: HIV infection is a disease associated with chronic inflammation and immune activation. Antiretroviral therapy reduces inflammation, but not to levels in comparable HIV-negative individuals. The HMG-coenzyme A reductase inhibitors (statins) inhibit several pro-inflammatory processes and suppress immune activation, and are a logical therapy to assess for a possible salutary effect on HIV disease progression and outcomes.
- Sep 10 Sat 2011 10:06
[Medscape Medical News]New Guidelines for Preventing Colchicine Drug Interactions
A new set of evidence-based guidelinesprovides an algorithm for reducing colchicine doses to prevent toxicity in patients who are also taking drugs such as cyclosporine, ketoconazole, ritonavir, clarithromycin, azithromycin, verapamil extended release (ER), or diltiazem ER. The research group was led by Robert A. Terkeltaub, MD, from the Veterans Administration San Diego Medical Center in California, and the new report appears in the August issue of Arthritis & Rheumatism.
- Sep 09 Fri 2011 10:08
[Medscape][Pharmacotherapy]Effect of Acetaminophen on International Normalized Ratio in Patients Receiving Warfarin Therapy
Abstract and Introduction
Abstract
The literature suggesting a relevant interaction between acetaminophen and warfarin is inconsistent. Considering the ubiquitous use of acetaminophen, a review of the effects on international normalized ratio (INR) in patients taking warfarin was necessary. Thus, we performed a search of the PubMed (1966–November 2010) and International Pharmaceutical Abstracts (1970–November 2010) databases to review the available literature addressing an acetaminophen-warfarin interaction and its possible mechanisms.
- Sep 08 Thu 2011 07:38
[Medscape Alerts]TNF Blockers Get Boxed Warning on 2 Bacterial Infections
The boxed warning on the labels of all tumor necrosis factor alpha (TNF-alpha) inhibitors will be updated to warn about the risk for serious and sometimes fatal infection from 2 bacterial pathogens,Legionella and Listeria, the US Food and Drug Administration (FDA) announced today.
- Sep 02 Fri 2011 05:12
[Medscape Medical News][oncology]Alpharadin Improves Survival in Advanced Prostate Cancer
An investigational radiopharmaceutical has been found to improve survival in patients with advanced prostate cancer in a phase 3 study that is still ongoing. Only 4 other products have managed to show such a survival benefit.
- Aug 12 Fri 2011 07:05
[Medscape Pharmacists][Ask the Experts]Which Is Better: Vitamin D2 or D3? 維他命D2和D3哪一個比較好?
Question
Which oral formulation of vitamin D is preferred: vitamin D2 (ergocalciferol) or vitamin D3 (cholecalciferol)?
以口服來說,維他命D2和d3哪一個好呢?
- Aug 09 Tue 2011 10:06
[Medscape Education Clinical Briefs]CDC Issues Revised Guidelines for Postpartum Contraceptive Use 疾管局針對產後避孕提出新的指引
Clinical Context
- Aug 08 Mon 2011 07:03
[Medscape Alerts]FDA: Avoid Methylene Blue or Linezolid With Serotonergics
Physicians generally should avoid prescribing either methylene blue or linezolid (Zyvox,Pfizer) in combination with serotonergic agents such as paroxetine or duloxetine to avoid a potential drug interaction causing a dangerous condition called serotonin syndrome, the US Food and Drug Administration (FDA) announced today.
- Aug 07 Sun 2011 08:17
[Medscape Pharmacists][Ask the Experts]Probiotics for Antibiotic-Associated Diarrhea? 益生菌治療抗生素引起的腹瀉?
Question:
Please clarify the use of probiotics with concomitant antibiotic therapy. I see this combination in practice and am unclear whether it has clinical benefit for preventing antibiotic-associated diarrhea.